Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.
Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...
Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.
Shares of Omeros fell almost 10% after analysts' downgraded the biotech.